GET THE APP

Cardiovascular Health Disparities: Addressing Inequities in Access, Diagnosis and Treatment
..

Journal of Coronary Heart Diseases

ISSN: 2684-6020

Open Access

Commentary - (2023) Volume 7, Issue 4

Cardiovascular Health Disparities: Addressing Inequities in Access, Diagnosis and Treatment

Ralph Maddison*
*Correspondence: Ralph Maddison, Department of Cardiology, University of Paris-Saclay, F-75252, Saclay, France, Email:
Department of Cardiology, University of Paris-Saclay, F-75252, Saclay, France

Received: 01-Aug-2023, Manuscript No. jchd-23-115992; Editor assigned: 02-Aug-2023, Pre QC No. P-115992; Reviewed: 17-Aug-2023, QC No. Q-115992; Revised: 23-Aug-2023, Manuscript No. R-115992; Published: 31-Aug-2023 , DOI: 10.37421/2684-6020.2023.7.191
Citation: Maddison, Ralph. “Cardiovascular Health Disparities: Addressing Inequities in Access, Diagnosis and Treatment.” J Coron Heart Dis 7 (2023): 191.
Copyright: © 2023 Maddison R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Description

Cardiovascular diseases remain the leading cause of death worldwide. Despite significant advancements in the prevention, diagnosis, and treatment of CVDs, there exist profound disparities in cardiovascular health outcomes among various demographic groups. This research article explores the underlying factors contributing to these disparities, with a particular focus on access to healthcare, timely diagnosis, and effective treatment. It also discusses potential strategies and interventions to mitigate these inequities and promote cardiovascular health equity.

Cardiovascular diseases encompass a group of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, stroke, and hypertension [1-3]. These conditions collectively account for a significant global health burden, contributing to nearly 18 million deaths annually, according to the World Health Organization. While considerable progress has been made in understanding the risk factors and developing interventions to combat CVDs, a striking feature of these diseases is the glaring disparities in their occurrence, diagnosis, and management among diverse populations.

One of the most pervasive contributors to cardiovascular health disparities is socioeconomic status. Individuals with lower income and education levels often face barriers in accessing healthcare services. This may result in delayed or inadequate preventive care, lack of access to regular screenings, and limited awareness of heart-healthy lifestyles. Racial and ethnic minorities, particularly in the United States, experience significant disparities in access to healthcare. These disparities are exacerbated by systemic factors such as discrimination, lack of insurance coverage, and geographic barriers to care. As a result, minority populations are at a higher risk of undiagnosed or poorly managed cardiovascular conditions.

Gender-based disparities exist in cardiovascular disease diagnosis. Women often present with atypical symptoms, leading to misdiagnosis or delayed diagnosis. Additionally, gender bias in healthcare settings can result in underestimating the severity of cardiovascular symptoms in women. Access to advanced diagnostic technologies, such as cardiac imaging and biomarker assays, varies across regions and healthcare settings. Rural and underserved areas may lack the resources needed for early and accurate CVD diagnosis, contributing to disparities in rural populations. Treatment guidelines for CVDs may not always consider the unique needs and cultural factors of diverse populations. Healthcare providers must be culturally competent and aware of the specific challenges faced by minority groups to provide effective care [4,5].

Socioeconomic factors, including income and access to pharmacies, can impact medication adherence rates among individuals with CVD. Patients from lower-income backgrounds may struggle to afford prescribed medications, leading to suboptimal treatment outcomes. Efforts to reduce cardiovascular health disparities should involve the development and implementation of health equity initiatives. These initiatives must address the social determinants of health, including education, income, housing, and access to healthy foods. Culturally tailored interventions can help bridge the gap in cardiovascular care. These interventions should consider the unique needs and preferences of various demographic groups and be designed to increase awareness, improve access, and enhance treatment adherence. Training healthcare providers in cultural competence and sensitivity is essential for reducing disparities in cardiovascular care. Additionally, implementing guidelines that consider gender and racial differences in disease presentation can lead to more accurate diagnoses.

Cardiovascular health disparities persist as a significant public health challenge, resulting from a complex interplay of socioeconomic, racial, and gender-related factors. Addressing these disparities requires a multifaceted approach that encompasses access to care, early diagnosis, and effective treatment. By implementing health equity initiatives, culturally tailored interventions, and provider education, we can work towards a future where all individuals have an equal opportunity to achieve optimal cardiovascular health. Reducing these disparities not only improves individual lives but also contributes to overall public health and well-being.

Acknowledgement

None.

Conflict of Interest

Authors declare no conflict of interest.

References

  1. Wolf, Philip A., Robert D. Abbott and William B. Kannel. "Atrial fibrillation as an independent risk factor for stroke: The Framingham Study." Stroke 22 (1991): 983-988.
  2. Google Scholar, Crossref, Indexed at

  3. Magnussen, Christina, Teemu J. Niiranen, Francisco M. Ojeda and Francesco Gianfagna, et al. "Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: Results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)." Circulation 136 (2017): 1588-1597.
  4. Google Scholar, Crossref, Indexed at

  5. Kim, Michael H., Stephen S. Johnston, Bong-Chul Chu and Mehul R. Dalal, et al. "Estimation of total incremental health care costs in patients with atrial fibrillation in the United States." Circ Cardiovasc Qual Outcomes 4 (2011): 313-320.
  6. Google Scholar, Crossref, Indexed at

  7. Wright, Alison K., Milton Fabian Suarez-Ortegon and Stephanie H. Read. "Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings." Circulation 142 (2020): 1925-1936.
  8. Google Scholar, Crossref, Indexed at

  9. Musunuru, Kiran and Sekar Kathiresan. "Genetics of common, complex coronary artery disease." Cell 177 (2019): 132-145.
  10. Google Scholar, Crossref, Indexed at

arrow_upward arrow_upward